An In Vitro Model of the Blood–Brain Barrier for the Investigation and Isolation of the Key Drivers of Barriergenesis
Advanced Healthcare Materials · 2024-12 · 13 (32)
DOI: 10.1002/adhm.202303777 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 05.08.2024. Verfasst von Christina Schofield und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for the Cellular Microenvironment, University of Glasgow, Glasgow, G11 6EW, UK. Hauptthemen laut MEDLINE: Blood-Brain Barrier. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 European Research Council, Engineering and Physical Sciences Research Council, Spanish Ministry of Science and Innovation.
Abstract (Originalsprache)
The blood–brain barrier (BBB) tightly regulates substance transport between the bloodstream and the brain. Models for the study of the physiological processes affecting the BBB, as well as predicting the permeability of therapeutic substances for neurological and neurovascular pathologies, are highly desirable. Existing models, such as Transwell utilizing‐models, do not mimic the extracellular environment of the BBB with their stiff, semipermeable, non‐biodegradable membranes. To help overcome this, we engineered electrospun membranes from poly L‐lactic acid in combination with a nanometric coating of poly(ethyl acrylate) (PEA) that drives fibrillogenesis of fibronectin, facilitating the synergistic presentation of both growth factors and integrin binding sites. Compared to commercial semi‐porous membranes, these membranes significantly improve the expression of BBB‐related proteins in brain endothelial cells. PEA‐coated membranes in combination with different growth factors and extracellular protein coatings reveal nerve growth factor (NGF) and fibroblast growth factor (FGF‐2) caused formation of better barriers in vitro. This BBB model offers a robust platform for studying key biochemical factors influencing barrier formation that marries the simplicity of the Transwell model with the highly tunable electrospun PEA‐fibronectin membranes. This enables the generation of high‐throughput drug permeability models without the need of complicated co‐culture conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for the Cellular Microenvironment, University of Glasgow, Glasgow, G11 6EW, UK.
- School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, G12 8TA, UK.
- Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology (BIST), Barcelona, 08028, Spain.
- Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
ORCID-Profile: Manuel Salmeron-Sanchez
Förderung
- H2020 European Research Council
- Engineering and Physical Sciences Research Council
- Spanish Ministry of Science and Innovation
- Ministerio de Ciencia e Innovación
Zitieren
APA
Schofield, C., Sarrigiannidis, S., Moran-Horowich, A., Jackson, E., Rodrigo-Navarro, A., van Agtmael, T., Cantini, M., Dalby, M. J., & Salmeron-Sanchez, M. (2024). An In Vitro Model of the Blood–Brain Barrier for the Investigation and Isolation of the Key Drivers of Barriergenesis. Advanced Healthcare Materials, 13(32). https://doi.org/10.1002/adhm.202303777
Vancouver
Schofield C, Sarrigiannidis S, Moran-Horowich A, Jackson E, Rodrigo-Navarro A, van Agtmael T, et al. An In Vitro Model of the Blood–Brain Barrier for the Investigation and Isolation of the Key Drivers of Barriergenesis. Advanced Healthcare Materials. 2024;13(32). doi:10.1002/adhm.202303777
BibTeX
@article{Schofield2024,
author = {Schofield, Christina and Sarrigiannidis, Stylianos and Moran-Horowich, Alejandro and Jackson, Emma and Rodrigo-Navarro, Aleixandre and van Agtmael, Tom and Cantini, Marco and Dalby, Matthew J and Salmeron-Sanchez, Manuel},
title = {An In Vitro Model of the Blood–Brain Barrier for the Investigation and Isolation of the Key Drivers of Barriergenesis},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {32},
doi = {10.1002/adhm.202303777}
}
EUVIMED